Michael Barbella, Managing Editor02.10.24
There was no shrugging off this week's top traffic driver on ODT's website.
Capturing the top spot on the most-read list was an in-depth examination of shoulder replacement implants and enabling technologies, as well as manufacturing partnerships. Specifically, the magazine feature detailed the latest advancements in the sector from Exactech and Zimmer Biomet, and discussed manufacturing partnerships with an executive from Avalign Technologies, whose orthopedic division makes implants and instruments for orthopedic, spine, and trauma applications.
Also shouldering responsibility for site traffic this past week was Boston Scientific, Globus and Treace Medical Concepts, the latter of which shared three-year interim clinical data from its ALIGN3D post-market study supporting use of its Lapiplasty procedure to treat bunions. Results showed an early return to weight bearing in a walking boot at an average 8.4 days; and an 81% reduction in pain measured using the Visual Analog Scale (“VAS”) at 24 months (n=156), among other data.
Boston Scientific amassed pageviews with news it had gained an expanded indication from the FDA for its WaveWriter spinal cord stimulation (SCS) systems to treat chronic low back leg pain in patients without previous back surgery. The expansion is supported by positive one-year data from the SOLIS (SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery) RCT, which met its primary endpoint (≥50% reduction in pain) at three-month interval and showed the WaveWriter SCS provide significant and sustained pain relief.
Globus Medical, on the other hand, enticed cybervisitors by promoting its chief financial officer, while startup Anatomic Implants responded in kind with a sneak peek at the world's first 3D printed toe joint replacement, which will be on display next week at the American Academy of Orthopaedic Surgeons (AAOS) 2024 Annual Meeting in San Francisco.
Capturing the top spot on the most-read list was an in-depth examination of shoulder replacement implants and enabling technologies, as well as manufacturing partnerships. Specifically, the magazine feature detailed the latest advancements in the sector from Exactech and Zimmer Biomet, and discussed manufacturing partnerships with an executive from Avalign Technologies, whose orthopedic division makes implants and instruments for orthopedic, spine, and trauma applications.
Also shouldering responsibility for site traffic this past week was Boston Scientific, Globus and Treace Medical Concepts, the latter of which shared three-year interim clinical data from its ALIGN3D post-market study supporting use of its Lapiplasty procedure to treat bunions. Results showed an early return to weight bearing in a walking boot at an average 8.4 days; and an 81% reduction in pain measured using the Visual Analog Scale (“VAS”) at 24 months (n=156), among other data.
Boston Scientific amassed pageviews with news it had gained an expanded indication from the FDA for its WaveWriter spinal cord stimulation (SCS) systems to treat chronic low back leg pain in patients without previous back surgery. The expansion is supported by positive one-year data from the SOLIS (SCS as an Option for Chronic Low Back and/or Leg Pain Instead of Surgery) RCT, which met its primary endpoint (≥50% reduction in pain) at three-month interval and showed the WaveWriter SCS provide significant and sustained pain relief.
Globus Medical, on the other hand, enticed cybervisitors by promoting its chief financial officer, while startup Anatomic Implants responded in kind with a sneak peek at the world's first 3D printed toe joint replacement, which will be on display next week at the American Academy of Orthopaedic Surgeons (AAOS) 2024 Annual Meeting in San Francisco.